Cardio Diagnostics Holdings Stock Math Transform Price Common Logarithm
| CDIO Stock | USD 4.56 -0.20 -4.20% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cardio Diagnostics Price Common Logarithm is logarithm with base 10 applied on the entire pricing series.
Cardio Diagnostics Technical Analysis Modules
Most technical analysis of Cardio Diagnostics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cardio from various momentum indicators to cycle indicators. When you analyze Cardio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. Liquidity and trading activity can influence how quickly new information is reflected in Cardio Diagnostics's price. Lower trading activity may introduce occasional variability in execution conditions. Cardio Diagnostics has a market cap of 8.33 M, ROE of -110.7%.
Methodology
Unless otherwise specified, financial data for Cardio Diagnostics Holdings is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cardio (USA Stocks:CDIO) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Cardio Diagnostics Holdings is covered by 1 analyst. Representative analyst firms may include Stifel, J.P. Morgan, Bernstein Research, UBS Investment Research, Oppenheimer & Co., among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Michael Smolkin - Member of Macroaxis Board of DirectorsSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardio Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardio Diagnostics' short interest history, or implied volatility extrapolated from Cardio Diagnostics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested few shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Social Domain Invested few shares | |
 | ESG Investing Invested few shares | |
 | Video Games Invested few shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Artificial Intelligence Invested few shares | |
 | Driverless Cars Invested few shares | |
More Resources for Cardio Stock Analysis
Understanding Cardio Diagnostics typically begins with financial statements and long-term trend review. Ratio context helps frame profitability, efficiency, and growth trends for Cardio Diagnostics Holdings Stock. Outlined below are key reports that provide context for Cardio Diagnostics Holdings Stock:Cardio Diagnostics has a market cap of 8.33 M, operating margin of -599.51%, ROE of -110.7%. Review Trending Equities for broader portfolio context. This reflects a position in Cardio Diagnostics Holdings within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. Analysis related to Cardio Diagnostics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Earnings Share -11.91 | Revenue Per Share | Quarterly Revenue Growth -0.57 | Return On Assets | Return On Equity |
Cardio Diagnostics's market price can diverge from book value, the accounting figure shown on Cardio's balance sheet. Cardio Diagnostics' market capitalization is 8.33 M. A P/B ratio of 1.07 indicates the market values Cardio Diagnostics above its accounting book value. Enterprise value stands at 2.82 M. Intrinsic value reflects what Cardio Diagnostics' fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish Cardio Diagnostics' value from its trading price, which are computed with different methods. For Cardio Diagnostics, key inputs include a P/B ratio of 1.07, ROE of -110.7%, and revenue of 34.89 K. The quoted price is simply the exchange level where supply meets demand.